Artia Global Partners LP Axsome Therapeutics, Inc. Transaction History
Artia Global Partners LP
- $517 Billion
- Q2 2024
A detailed history of Artia Global Partners LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 87,848 shares of AXSM stock, worth $7.82 Million. This represents 1.37% of its overall portfolio holdings.
Number of Shares
87,848
Previous 87,848
-0.0%
Holding current value
$7.82 Million
Previous $7.01 Billion
0.88%
% of portfolio
1.37%
Previous 1.41%
Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
289Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$413 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$294 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$210 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$165 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.82B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...